News | News By Subject | News by Disease News By Date | Search News

Colon Cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
European Regulator Calls XBiotech (XBIT)'s Phase III Cancer Data Unreliable     7/15/2016
Shares Jump as Foamix Pharma (FOMX)'s FDX104 Shows Efficacy in Phase II Study     12/3/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Data Presented Supporting Almac Group Developed Colon Signature As A Significant Predictor Of Risk Of Recurrence In Stage II Colon Cancer     1/28/2014
Amgen (AMGN) Late-Stage Trial of Colon Cancer Drug Meets Goal     5/10/2013
Genentech (RHHBY)'s Immune Therapy Cancer Drug Shows Promise in Early Study     4/12/2013
Genentech (RHHBY)'s Avastin Approved for Wider Use in Colorectal Cancer     1/24/2013
Cipla Ltd. Slashes Cancer Drug Prices by Up to 64 Pct     11/8/2012
FDA Approves Bayer AG (BAY.F) Colon Cancer Drug Stivarga     9/28/2012
Merck KGaA (MKGAF.PK)'s Erbitux Fails in Colon Cancer Study     5/9/2012
Sanofi (France) (SAN.PA) Unveils Mixed News for Zaltrap Cancer Drug     4/6/2012
Eli Lilly and Company (LLY)'s Erbitux Fails In European Colon Cancer Study     10/11/2010
Roche (RHHBY)'s Avastin Fails to Help Early-Stage Colon Cancer Patients in Study     9/21/2010

News from Around the Web
Nano-Lipid Particles From Edible Ginger Could Improve Drug Delivery For Colon Cancer, Georgia State University Study Finds     9/7/2016
Landmark Study Gives Clearest Picture Of Genetic Causes Of Bowel Cancer, Institute Of Cancer Research Reveals     6/27/2016
Aspirin Linked To Colon Cancer Survival, Biotechnology Centre In Oslo Study     6/13/2016
Walnuts May Improve Your Colon Health, University of Connecticut Study     6/6/2016
Time To Drop The "No-Eating Rule" Before Colonoscopy? University of California, Irvine Study     5/25/2016
Better Survival For Colon Cancer Patients With Left-Sided Tumors, UCSF Study     5/19/2016
How Diet Influences Colon Cancer, MIT Study     3/3/2016
Plum Good Health Benefits, Texas A&M University Study     9/28/2015
Colorful Potatoes May Pack Powerful Cancer Prevention Punch, Penn State University Study     8/28/2015
An Aspirin A Day May Keep Colon Cancer Away, Annals Of Internal MedicineM Reveals     8/25/2015
Drinking Coffee Daily May Boost Colon Cancer Survival, Dana-Farber Cancer Institute Study     8/18/2015
Could Swallowable Cameras Replace The Colonoscopy?     7/24/2015
Diet Swap Shows How Junk Food Ups Your Cancer Risk, University of Pittsburgh and Imperial College London Study     5/1/2015
How Vitamin D May Fight Colorectal Cancer, Dana-Farber Cancer Institute Study     1/16/2015
Testosterone Linked To Colon Cancer Growth, University of Missouri Study     12/16/2014

Press Releases
Viral Gene Announces Breakthrough In Colon Cancer: New Vaccine Targets Enzyme To Help Destroy Metastatic Tumor Cells     11/22/2016
New Immune Design Corporation (IMDZ) Data Highlights Expanded Product Potential Of Zvex® Platform At The 2016 SITC Annual Meeting     11/11/2016
Hitachi, Ltd. (HIT) Developing Urine Test for Breast and Colon Cancer     6/14/2016
Bayer (BAY) Collaborates With U.S. National Surgical Adjuvant Breast And Bowel Project (NSABP) To Investigate Stivarga (Regorafenib) Tablets As Additional Adjuvant Therapy In Colon Cancer     6/1/2016
Agena Biosciences Launches In Vitro Diagnostic Tests For Lung And Colon Cancer In Europe     4/4/2016
Medtronic (MDT) Snags Expanded Indication for Pillcam Colon 2     3/31/2016
Helomics Launches Genefx Colon To Identify Patients With High Risk Stage II Colon Cancer     3/15/2016
Data On Immunology Effects Of Provectus Biopharmaceuticals Inc. PV-10 In Colon Cancer Presented At 11th Annual ASC Meeting     2/3/2016
Sucampo (SCMP) Forks Over $190 Million to License Prevention Pharma's Colon Cancer Drug     1/12/2016
PharmaCyte (PMCB) Provides Update On Malignant Ascites And New Colon Cancer Studies     12/7/2015
Foamix Pharmaceuticals, Ltd. (FOMX) To Host Conference Call & Webcast To Discuss Topline Results From Phase II Study Of FDX-104 In Acneiform Rash Associated With Targeted Antibody Treatments For Colon And Head And Neck Cancers     12/3/2015
Rosetta Genomics Ltd. (ROSG) Launches BRAF Mutation Assay     10/12/2015
Bionomics Limited (BNO.AX) Announces Extension Of Strategic Collaboration With Merck & Co. (MRK) For The Discovery And Development Of Novel Pain Medications     10/8/2015
EXACT Sciences (EXAS) Tanked Following Colon Cancer Screening Snub     10/7/2015
Hutchison China MediTech (Chi-Med) Release: Second Proof-Of-Concept Trial Of Fruquintinib Achieves Its Primary Endpoint     9/4/2015

//-->